Nanobiotix S.A. (EPA:NANO)
28.54
-0.22 (-0.76%)
Apr 24, 2026, 4:12 PM CET
Nanobiotix Employees
Nanobiotix had 103 employees as of June 30, 2025.
Employees
103
Change
n/a
Growth
n/a
Revenue / Employee
€316,437
Profits / Employee
€232,631
Market Cap
1.39B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 103 | - | - | 103 | 0 |
| Dec 31, 2024 | 108 | 6 | 5.88% | 108 | 0 |
| Dec 31, 2023 | 102 | 0 | - | 102 | 0 |
| Dec 31, 2022 | 102 | 2 | 2.00% | 102 | 0 |
| Dec 31, 2021 | 100 | 10 | 11.11% | 100 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| Genfit | 188 |
| Innate Pharma | 174 |
| MedinCell | 145 |
| Transgene | 145 |
| DBV Technologies | 117 |
| Inventiva | 77 |
Nanobiotix News
- 4 days ago - Nanobiotix Announces Positive Preclinical Data For Nanoprimer In LNP-DNA Delivery - Nasdaq
- 4 days ago - Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology - GlobeNewsWire
- 16 days ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 23 days ago - Nanobiotix FY25 Net Loss Narrows; Expects Cash Runway Through Early 2028; Stock Down - Nasdaq
- 23 days ago - NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 - GlobeNewsWire
- 4 weeks ago - Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process - Benzinga
- 4 weeks ago - Nanobiotix (NBTX) Addresses Takeover Rumors - GuruFocus